MSN Laboratories Ltd.
 
 
 
 
Active Pharmaceutical Ingredients
  Infrastructure
  Quality Management
  Regulatory
  Contract Manufacturing
Active Pharmaceutical Ingredients - Regulatory

MSN has well Qualified RA team who supports various customers throughout the World by providing Regulatory Guidance and Documents required for Regulatory Submission. RA has a vast exposure to various International Regulatory Guidelines, regulations and pharmacopoeias and committed to stay at the forefront of the evolving regulations by working closely with regulatory agencies and industry association groups.

The Major Activities of the RA includes
Interactions with various Regulatory Bodies
Preparation and filing of DMF’s of MSN API’s and address to queries from Regulatory Bodies
Assisting Regulatory Authorities during Audits
Chemistry, manufacturing, and control documentation to support IND, NDA’s and ANDA’s



MSN Regulatory Filings
Product USDMF Number EDMF Number CEP Number CEP Number Europe Regulatory Procedures
Alfuzosin Hydrochloride 20867 CEP 2006-208 / Granted    
Aprepitant Q4 – 2009        
Atorvastatin Calcium (Amorphous) 22785      
Atorvastatin Calcium (Form-1) 21892      
Bosentan Q4 – 2009      
Carbinoxamine Maleate 21301      
Clopidogrel Besylate       NA
Clopidogrel Bisulfate (Form-1) 21309   Q4 – 2009 NA
Darifenacin Hydrobromide 22225 NA      
Duloxetine Hydrochloride 20996      
Dutasteride Q4 – 2009        
Eplerenone Q4 – 2009      
Ezetimibe 21554     DCP
Finasteride   CEP 2008-024 / Granted   NA & MRP
Finasteride USP 21276        
Ketorolac Trometamol 21276 CEP 2008-144    
Ketorolac Tromethamine USP 21693        
Memantine Hydrochloride 22112 CEP 2008-144   DCP & NA
Montelukast Sodium 20580 / 22484 CEP 2008-144 2008-142  
Moxifloxacin          
Moxifloxacin HCl [Monohydrate] 20755 CEP 2007-355 / Granted    
Olmesartan Medoxomil Q4 – 2009        
Paliperidone Q4 – 2009        
Pantoprazole Sodium 20850      
Pitavastatin Calcium Q4 – 2009        
Pregabalin 22111   2009-030  
Ranolazine 22350      
Rosuvastatin Calcium 20712   2008-008 / 2009-040 DCP & NA
Solifenacin succinate Q4 – 2009        
Sumatriptan Succinate 22482   CEP 2009-096    
Telmisartan 22731 CEP 2009-108    
Terbinafine Hydrochloride 20413 CEP 2006-157 / Granted   NA
Voriconazole 21523   2009-077  
  Privacy Policy | Terms of Use | Disclaimer